{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Muiru AN"],"funding":["National Institute of Neurological Disorders and Stroke","Eunice Kennedy Shriver National Institute of Child Health and Human Development","National Institute on Alcohol Abuse and Alcoholism","National Institute of Diabetes and Digestive and Kidney Diseases","National Institute of Nursing Research","National Heart, Lung, and Blood Institute","National Institute on Deafness and Other Communication Disorders","Ontario Ministry of Health and Long-Term Care","National Institutes of Health","Health Resources and Services Administration","National Human Genome Research Institute","Canadian Institutes of Health Research","National Institute on Aging","National Institute of Allergy and Infectious Diseases","Agency for Healthcare Research and Quality","Centers for Disease Control and Prevention","NIDDK NIH HHS","National Cancer Institute","National Institute of Mental Health","National Institute of Dental and Craniofacial Research","National Institute on Drug Abuse"],"pagination":["461-468"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10169400"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["76(3)"],"pubmed_abstract":["<h4>Background</h4>The impact of adopting a race-free estimated glomerular filtration rate (eGFR) creatinine (eGFRcr) equation on racial differences in chronic kidney disease (CKD) progression among people with human immunodeficiency virus (PWH) is unknown.<h4>Methods</h4>We defined eGFR stages using the original race-adjusted Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) eGFRcr equation and the new race-free CKD-EPI eGFRcr equation. We then estimated 5-year probabilities of transitioning from baseline kidney function to more advanced eGFR stages and examined the association of race (black vs white) with rates of CKD progression using Markov models.<h4>Results</h4>With the race-adjusted eGFRcr equation, black participants (n = 31 298) had a lower risk of progressing from eGFR"],"journal":["Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"],"pubmed_title":["Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study."],"pmcid":["PMC10169400"],"funding_grant_id":["K23 DK119562","K23EY013707","P30MH62246","U01HL146208","R24AI067039","U01AI038855","U10EY008067","U01HL146333","U01AI069918","U01AI038858","CDC-200-2006-18797","K24AI118591","F31DA037788","U01AI069434","UL1RR024131","TGF-96118","R01AA016893","CBR-94036","HCP-97105","U54GM133807","P30AI036219","U10EY008057","N02CP055504","U01AI068636","U01AA020790","G12MD007583","K24DA035684","U01AI068634","R01DA012568","KL2TR000421","F31AI124794","U01DA03629","U10EY008052","CDC-200-2015-63931","K24DA000432","R01DA026770","P30AI050409","U24AA020794","P30AI050410","P30AI110527","U01DA036935","N01CP01004","U01HL146194","P30AI027757","U01HL146193","U01HL146192","R01 AG053100","U01AI069432","90051652","UL1TR000004","UL1TR000083","CBR-86906","K01AI131895","K01AI093197","R01DA011602","N02CP91027","P30AI027763","90047713","Z01CP010176","U01HL146205","U01HL146204","U01HL146203","U01HL146202","U01HL146201","U01HL146245","Z01CP010214","U01HL146242","U01HL146241","P30AI094189","U01HL146240","U01AA013566","K24AI065298","P30AI027767"],"pubmed_authors":["Klein MB","Shlipak MG","Mayor AM","Koethe JR","Napravnik S","Crane HM","Madden E","John Gill M","Scherzer R","Estrella MM","Marconi VC","Muiru AN","Lucas GM","Althoff KN","Abraham AG","Horberg MA","Silverberg MJ","Moore RD"],"additional_accession":[]},"is_claimable":false,"name":"Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study.","description":"<h4>Background</h4>The impact of adopting a race-free estimated glomerular filtration rate (eGFR) creatinine (eGFRcr) equation on racial differences in chronic kidney disease (CKD) progression among people with human immunodeficiency virus (PWH) is unknown.<h4>Methods</h4>We defined eGFR stages using the original race-adjusted Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) eGFRcr equation and the new race-free CKD-EPI eGFRcr equation. We then estimated 5-year probabilities of transitioning from baseline kidney function to more advanced eGFR stages and examined the association of race (black vs white) with rates of CKD progression using Markov models.<h4>Results</h4>With the race-adjusted eGFRcr equation, black participants (n = 31 298) had a lower risk of progressing from eGFR","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2025-04-26T14:27:42.387Z","creation":"2025-04-06T14:33:21.131Z"},"accession":"S-EPMC10169400","cross_references":{"pubmed":["36069064"],"doi":["10.1093/cid/ciac731"]}}